By
Ying-Che Huang
Yi-Yang Liu
Hui-Ying Liu
Yin-Lun Chang
Hung-Jen Wang
Yen-Ta Chen
Hao-Lun Luo
January 24, 2026
by Ying-Che Huang, Yi-Yang Liu, Hui-Ying Liu, Yin-Lun Chang, Hung-Jen Wang, Yen-Ta Chen, Hao-Lun Luo
January 24, 2026
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the renal cell carcinoma clinical updates you need to know from AACR 2026.
June 17, 2026
Kidney cancer research at ESMO25: Dana-Farber's Marc Machaalani, MD, shares 3 key takeaways from his presentation on the protein MAdCAM-1 and its ability to predict outcomes in patients with metastatic renal cell carcinoma.
November 5, 2025
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from March 1 - 15.
